Catalent is the leading global leader in advanced drug delivery
technologies and development solutions, providing worldwide
clinical and commercial supply capabilities for drugs, biologics,
and consumer health products. With over 80 years serving the
industry, we have proven expertise in bringing more customer
products to market faster, enhancing product performance and
ensuring reliable product supply.
We serve thousands of innovators, both established and
emerging, in over 80 markets, including 48 of the top 50
pharmaceutical and 41 of the top 50 biotech companies. Our
team of over 1, 400 talented scientists has supported over half of
all new molecular entities approved by the FDA in the past 10
years, and we have more than 450 active development programs
for new customer products. We have 18 development teams in
10 markets. Over 30 global sites serve over 1,000 customers in
over 80 countries supplying over 70 billion units annually. Our
significant intellectual property includes over 1, 300 patents and
Whether you are looking for a single, tailored solution or
multiple answers throughout your product’s lifecycle, we can
improve the total value of your treatments — from discovery to
market and beyond.
Catalent. More products. Better treatments.
With our wide range of expert services — including analytical,
biologics, pre-formulation and formulation — we drive faster,
more efficient development timelines and produce better products.
Catalent has recently bolstered its capabilities and capacity with the
acquisition of Pharmatek, and now offers the broadest toolkit of
development and bioavailability enhancing technologies available.
Our robust GPEx® mammalian
cell line engineering technology,
accelerates large molecule drugs
from discovery to clinic and
our award winning OptiForm®
Solution Suite combines our
delivery technologies into a
robust, data driven, parallel
screening platform which
quickly assesses the optimal
formulation pathways for both
small molecules and biologics for oral delivery potential. With
our expertise and our extensive formulation capabilities across
a wide range of dose forms, we can solve even the most complex
bioavailability, solubility and permeability, challenges.
We are a world leader in drug delivery solutions with a proven
track record of helping our customers create better treatments by
boosting bioavailability, solubility, and permeability; improving ease
and route of administration; and increasing patient compliance.
Our unique delivery technologies — including RP Scherer softgel
and OptiShell™ capsules, Zydis® fast-dissolve, controlled release
and OptiMelt® hot melt extrusion, as well as inhaled and injectable
dose forms — improve how products work in and for patients.
We reliably supply our customers through operational and quality
excellence, and we have regulatory inspection results exceeding
the industry average. As a seamless extension of your supply
chain, we offer global, integrated manufacturing and packaging
solutions to take your product from design to clinical trial to plant
and to pharmacy. We manufacture oral, sterile and inhaled dose
forms and produce biologics for pre-clinical and clinical studies.
Catalent Pharma Solutions
14 Schoolhouse Road
Somerset, NJ 08873
(+1 888 765 8846)